Immun4Cure Cohort of Autoimmune Diseases (NCT07515638) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Immun4Cure Cohort of Autoimmune Diseases
500 participantsStarted 2026-05-01
Plain-language summary
This prospective cohort study aims to constitute a 500-participant database and biobank including 450 adults with systemic autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis) and 50 healthy controls.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria Participants:
Group 1: RA
* Adults ≥18 years
* Patient followed as part of their MAI in one of the departments participating in the study at UHM
* Confirmed diagnosis according to international criteria :ACR/EULAR 2010
Group 2: LES
* Adults ≥18 years
* Patient followed as part of their MAI in one of the departments participating in the study at UHM
* Confirmed diagnosis according to international criteria :ACR/EULAR 2019
Group 3: SSc
* Adults ≥18 years
* Patient followed as part of their MAI in one of the departments participating in the study at UHM
* Confirmed diagnosis according to international criteria :ACR/EULAR 2013
Group 4: Healthy Controls
* Adults ≥18 years
* No symptoms of autoimmune disease
* No first-degree family history of autoimmune disease
Exclusion Criteria (all groupes):
* Patients who have refused or are unable to give informed consent
* Inability to follow the subject during the study period
* Participation in another interventional study that includes an exclusion period that is still ongoing
* Pregnant women
* Not affiliated with a social security scheme
* Patients without a national insurance number
* Persons under judicial protection, guardianship or trusteeship
* Persons deprived of their liberty
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
AUC-ROC discriminant performance of multi-omic biomarkers